Literature DB >> 6520176

Simultaneous determination of lidocaine and its metabolites in plasma and myocardium.

F A Luzzi, T L Wenger, J K Klinger, A Barchowsky, H C Strauss.   

Abstract

No validated method exists for measuring lidocaine and its metabolites in myocardial tissue. We modified a previously described high-performance liquid chromatographic assay and applied it to plasma and to homogenized myocardial samples obtained from dogs that had received lidocaine by a double-infusion technique. Recovery of lidocaine, monoethylglycylxylidide and glycylxylidide after homogenization and extraction is reported. Assay variability, sensitivity and linearity over a wide range of sample sizes are also described. The results obtained with high-performance liquid chromatographic analysis are compared to quantitation of 14C-labeled lidocaine plus metabolites measured by an oxidation-scintillation technique. Myocardium to plasma partition coefficients for lidocaine, monoethylglycylxylidide and glycylxylidide were 2.16, 4.27, and 2.91, respectively.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6520176     DOI: 10.1016/s0378-4347(00)84722-2

Source DB:  PubMed          Journal:  J Chromatogr


  2 in total

1.  Effect of lidocaine on in vivo hepatic function.

Authors:  B Mets; R Hickman; U Neveling; M Emms; D O Chalton
Journal:  Dig Dis Sci       Date:  1993-12       Impact factor: 3.199

2.  Conversion of ouabain-induced ventricular tachycardia in dogs with epicardial lidocaine: pharmacodynamics and functional effects.

Authors:  A Sintov; W A Scott; K P Gallagher; R J Levy
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.